Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by Mole101on Feb 04, 2021 6:32pm
254 Views
Post# 32479719

RE:day off

RE:day offSomethings is happening , big wall at .115 with RBC the main holder and for weeks  they've been seating  at .007 with a Bid between 500k/1 million,it's taking down and put back every day 
Anon/ Canacord have been busy nibbling here and there 

 By Price


Price Total Volume Value
0.170 65,000 $11,050
0.160 58,000 $9,280
0.150 105,000 $15,750
0.145 12,500 $1,812
0.140 352,000 $49,280
0.135 31,000 $4,185
0.130 15,000 $1,950
0.125 44,472 $5,559
0.120 72,500 $8,700
0.115 370,950 $42,657
0.110 115,500 $12,705
0.105 51,000 $5,355
0.100 197,000 $19,700
0.095 61,500 $5,842
0.090 135,100 $12,159
0.085 188,000 $15,980
0.080 248,000 $19,840
0.075 177,000 $13,275
0.070 672,571 $47,079
0.065 45,000

<< Previous
Bullboard Posts
Next >>